The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Body Mass Index and Risk of Prostate Cancer in U.S. Health Professionals
Open accessAbstract
The relationship between body mass index (BMI) and prostate cancer risk may be complex because obesity is associated with various hormonal factors and because the influence of BMI may differ according to whether the cancers are hereditary or sporadic. We used data from the Health Professionals Follow-Up Study, in which 2896 incident cases of prostate cancer were reported from February 1, 1986, through January 31, 2000, to determine prospectively whether BMI was associated with the risk of hereditary (men <60 years of age or with a positive family history of prostate cancer) and sporadic (men > or =60 years of age and without such a family history) prostate cancer. The risk of prostate cancer in men with a higher BMI (> or =30 kg/m2) was lower than that in men with a lower BMI (23-24.9 kg/m2) but only if they were younger (<60 years old) (relative risk = 0.52, 95% confidence interval = 0.33 to 0.83; P(trend)<.001) or had a family history of prostate cancer (relative risk = 0.74, 95% confidence interval = 0.45 to 1.19; P(trend) =.01). However, for groups with more sporadic cancers, BMI had a weak, non-statistically significant positive association with prostate cancer. We observed statistically significant interactions between BMI and age (P(interaction)<.001, two-sided Wald test) and between BMI and family history of prostate cancer (P(interaction) =.006, two-sided Wald test). Patterns for BMI and waist circumference were similar. Because obesity is associated with lower circulating concentrations of testosterone, our results suggest the hypothesis that androgens may play a more direct role for early-onset or hereditary prostate cancers than for sporadic prostate cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Variably increased risk has been reported for cancers of the breast (postmenopausal) endometrium ovary gall bladder, stomach and esophagus, kidney, thyroid (papillary, follicular, and anaplastic but not medullary), colon, bladder, and pancreas.1733,1734,1739–1752”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1740]
Citations
Cites
Rimm, E. B., Giovannucci, E. L., Stampfer, M. J., Colditz, G. A., Litin, L. B., & Willett, W. C. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116211 · Cited by 2,104
Self-citationPlasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Self-citationValidity of Self-Reported Waist and Hip Circumferences in Men and Women
Rimm, E. B., Stampfer, M. J., Colditz, G. A., Chute, C. G., Litin, L. B., & Willett, W. C. (1990) · Epidemiology · doi:10.1097/00001648-199011000-00009 · Cited by 1,015
Self-citationLeptin and Androgens in Male Obesity: Evidence for Leptin Contribution to Reduced Androgen Levels
Isidori, A. M. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3673 · Cited by 559
Chasan-Taber, S., Rimm, E. B., Stampfer, M. J., Spiegelman, D., Colditz, G. A., Giovannucci, E., Ascherio, A., & Willett, W. C. (1996) · Epidemiology · doi:10.1097/00001648-199601000-00014 · Cited by 508
Self-citationSUIKKARI, A.-M., KOIVISTO, V. A., RUTANEN, E.-M., YKI-JÄRVINEN, H., KARONEN, S.-L., & SEPPÄLÄ, M. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-266 · Cited by 483
Kazemi-Esfarjani, P., Trifiro, M. A., & Pinsky, L. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.4.523 · Cited by 443
Field, A. E., Colditz, G. A., Willett, W. C., Longcope, C., & McKinlay, J. B. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962322 · Cited by 421
Self-citationBiochimica et biophysica acta. Protein structure and molecular enzymology
ScienceDirect (2002) · Cited by 395
Vermeulen, A. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.5.1140 · Cited by 346
Research works printed but not linked: 3
- Zumoff, 1988, Acta medica Scandinavica. Supplementum, 723, 153
- Giovannucci, 1997, Cancer Epidemiology Biomarkers & Prevention, 6, 557
- Giovannucci, 2002, Cancer Epidemiology Biomarkers & Prevention, 11, 985
Cited by
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Garofalo, C., & Surmacz, E. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20472 · Cited by 588
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Giovannucci, E., & Michaud, D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.050 · Cited by 543
Self-citationProstate‐specific antigen: A review of the validation of the most commonly used cancer biomarker
Hernández, J., & Thompson, I. M. (2004) · Cancer · doi:10.1002/cncr.20480 · Cited by 527
Metadata
- Authors
- Giovannucci, E., Rimm, E. B., Liu, Y., Leitzmann, M., Wu, K., Stampfer, M. J., & Willett, W. C.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Giovannucci, E.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-08-19
- Volume
- 95
- Issue
- 16
- Pages
- 1240-1244
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2168533683
- Cited by
- 258
- References
- 29
- Citations by year
- 2026: 3 · 2025: 2 · 2023: 4 · 2022: 7 · 2021: 2 · 2020: 3 · 2019: 7 · 2018: 2 · 2017: 5 · 2016: 12 · 2015: 15 · 2014: 13 · 2013: 11 · 2012: 14
- FWCI
- 10.37
- Type
- journal article
- Language
- en
- Open access
- green
- nrs.harvard.edu
- Licence
- cc-by
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Cancer Institute (CA055075)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Keywords
- body mass index, obesity, prostate cancer, hereditary prostate cancer, sporadic prostate cancer, family history (medicine), waist circumference, androgens, testosterone, age interaction, Health Professionals Follow-up Study
- MeSH terms
- Adult, Aged, Health Personnel, Humans, Male, Middle Aged, Prospective Studies, Prostatic Neoplasms, Risk Factors, United States, Body Mass Index, Incidence, Multivariate Analysis, Age Distribution, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Body Mass Index and Risk of Prostate Cancer in U.S. Health Professionals. https://app.cochat.ai/papers/10.1093/jnci/djg009
- The paper
- Giovannucci, E., Rimm, E. B., Liu, Y., Leitzmann, M., Wu, K., Stampfer, M. J., & Willett, W. C. (2003). Body Mass Index and Risk of Prostate Cancer in U.S. Health Professionals. JNCI Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djg009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.